| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 453.774.957 $ | +196.378.676 $ | +78,4 % | 13 | 459.385.195 $ | +459.385.195 $ | 12 | |||||
| PFIZER INC | PFE | → 0 | Neutral | 41.112.742 $ | -13.754.508 $ | -25,1 % | 1 | 54.867.250 $ | +54.867.250 $ | 1 | |
| ZIMMER BIOMET HOLDINGS, INC. | ZBH | → 0 | Neutral | 52.367.738 $ | +52.367.738 $ | 1 | |||||
| AbbVie Inc. | ABBV | → 0 | Neutral | 52.020.090 $ | +52.020.090 $ | 1 | |||||
| NOVARTIS AG | NVS | → 0 | Neutral | 50.021.442 $ | +50.021.442 $ | 1 | |||||
| ICU MEDICAL INC/DE | ICUI | → 0 | Neutral | 32.841.683 $ | -15.772.406 $ | -32,4 % | 1 | 48.614.089 $ | +48.614.089 $ | 1 | |
| HENRY SCHEIN INC | HSIC | → 0 | Neutral | 45.991.527 $ | +21.774.032 $ | +89,9 % | 1 | ||||
| PACS Group, Inc. | PACS | → 0 | Neutral | 43.975.169 $ | +43.975.169 $ | 1 | |||||
| BECTON DICKINSON & CO | BDX | → 0 | Schwach | 43.900.188 $ | +28.140.346 $ | +178,6 % | 1 | ||||
| ELI LILLY & Co | LLY | → 0 | Neutral | 34.336.026 $ | +34.336.026 $ | 1 | |||||
| STERIS plc | STE | → 0 | Neutral | 34.303.031 $ | +34.303.031 $ | 1 | |||||
| DEXCOM INC | DXCM | → 0 | Stark | 33.834.254 $ | +17.581.502 $ | +108,2 % | 1 | ||||
| INSMED Inc | INSM | → 0 | Neutral | 31.871.520 $ | +23.169.520 $ | +266,3 % | 1 | ||||
| INTUITIVE SURGICAL INC | ISRG | → 0 | Neutral | 31.200.264 $ | +5.339.134 $ | +20,6 % | 1 | 25.861.130 $ | +25.861.130 $ | 1 | |
| Olema Pharmaceuticals, Inc. | OLMA | → 0 | Neutral | 30.865.850 $ | +30.865.850 $ | 1 | |||||
| Revolution Medicines, Inc. | RVMD | → 0 | Schwach | 30.728.277 $ | +1.779.166 $ | +6,1 % | 1 | 28.949.111 $ | +28.949.111 $ | 1 | |
| GLOBUS MEDICAL INC | GMED | → 0 | Schwach | 30.530.796 $ | +7.200.516 $ | +30,9 % | 1 | ||||
| BIOGEN INC. | BIIB | → 0 | Stark | 28.508.972 $ | +28.508.972 $ | 1 | |||||
| NEUROCRINE BIOSCIENCES INC | NBIX | → 0 | Schwach | 27.656.442 $ | +27.656.442 $ | 1 | |||||
| Nuvalent, Inc. | NUVL | → 0 | Schwach | 27.063.035 $ | +27.063.035 $ | 1 | |||||
| Denali Therapeutics Inc. | DNLI | → 0 | Neutral | 26.111.405 $ | +15.269.073 $ | +140,8 % | 1 | ||||
| PTC THERAPEUTICS, INC. | PTCT | → 0 | Neutral | 25.628.121 $ | +25.628.121 $ | 1 | |||||
| 453.774.957 $ | +196.378.676 $ | +78,4 % | 13 | 459.385.195 $ | +459.385.195 $ | 12 | |||||